CMV Glycoprotein B Vaccine in Allograft Recipients

Clinical trial NCT00299260 · UNKNOWN

Trial details

NCT number: NCT00299260
Sponsor: University College, London
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Cytomegalovirus Infections

Start date: 2006-08-01
Primary completion: 2009-09-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.